New treatment Xadago to help 100,000 Canadians living with Parkinson’s

News

Author: Parkinson's Life editorsPublished: 5 May 2017

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

News image

More than 100,000 Canadians living with Parkinson’s will benefit from a new product to be launched in the country.

The drug known as ‘Xadago’, currently readily available in several countries across Europe, helps control motor symptoms and complications over a 24-month period.

Xadago will be the first new oral treatment for Parkinson’s in almost 15 years in Canada. On 21 March 2017 the Food and Drug Administration in the US approved the use of Xadago for the treatment of Parkinson’s as an add-on therapy to levodopa/carbidopa.

Go Back

Share this story

Comments


Related articles


appendix

Advances

Expert opinion: Parkinson’s and the appendix

Dr Viviane Labrie describes the link between the appendix and Parkinson’s

READ MORE
Maurice White

Global update

13 famous people you didn’t know had a connection with Parkinson’s

Did you know these famous people had a Parkinson’s connection?

READ MORE

sponsored article

Episodes

Podcast: Living with ‘advanced’ Parkinson’s disease

From coping with changing symptoms to keeping a positive attitude

READ MORE